FARMANNSO
InactiveInactive; last annual accounts for fiscal year 2024.
Signals
Two signals. The signal on the left, the evidence on the right.
+raises risk○neutral
raises risk · Negative equity
The 2024 annual accounts show negative equity and a net loss.
NBB · annual accounts 2024Equity per financial year
19202122232424
2019 to 2024 · latest year -€197,357
neutral · Latest accounts filed on time
The financial year that closed on 31-12-2024 was due by 31-07-2025 and was filed on 23-06-2025, 38 days ahead of the deadline.
NBB · 10 filingsDeviation from the deadline
2024
38 d early
2024
30 d early
2023
4 d early
2022
35 d late
2021
173 d late
2020
24 d early
2019
3 d early
← before the deadline
after the deadline →
tick = median of all Belgian filings
This company filed its last 7 accounts on average 16 days after the deadline; the Belgian median for financial year 2024 is 4 days before the deadline, and 38% of all filings were late.
Checked, nothing found (1)
Go further with this company
Who ran this company, and where was it based, on a date before the end?Company as of a date Which other companies belong to the same group?MULTIPHARMA GROUP · 10 companies
Investigating this company? Keep it with today's facts in a case file.
Financials · fiscal year 2024, full schema
Turnover
Not included in this filing
EBIT margin
Not included in this filing
Net result
-€1.1m
2024 · €120,054
Working capital
-€688,751▼ 461%
2024 · -€122,853
Trend over the years
Click a name to add, emphasise or remove a line.
Every figure with its change against the fiscal year before
favourable
unfavourable
Line20212022202320242024
Operating result€180,535▲ 7.0%€192,106▲ 6.4%€160,269▼ 16.6%€177,088▲ 10.5%-€9,676-
Net result€101,594▲ 12.8%€110,412▲ 8.7%€93,688▼ 15.1%€120,054▲ 28.1%-€1.1m-
Equity€667,695▲ 17.9%€778,107▲ 16.5%€871,795▲ 12.0%€951,849▲ 9.2%-€197,357-
Total assets€1.9m▲ 1.2%€1.8m▼ 6.8%€1.8m▲ 0.9%€1.8m▼ 2.7%€552,421-
Debt€1.3m▼ 5.8%€1.0m▼ 19.1%€943,510▼ 7.6%€814,249▼ 13.7%€749,778-
Working capital-€141,741▲ 19.1%-€94,409▲ 33.4%-€97,882▼ 3.7%-€122,853▼ 25.5%-€688,751-
Result per fiscal year
Operating resultNet result
Multiple fiscal year ends fall in the same calendar year; an annual trend is not displayed.
Balance-sheet composition
2024 in colour, 2024 as the grey bar beneath
Assets €552,421
Fixed assets
€491,394 ▼ 70.5%
Current assets
€61,027 ▼ 39.4%
Key figures and ratios
EBITDA
€8,632▼
2024 · €214,374
Cash flow
-€1.1m▼
2024 · €157,340
Solvency
-35.7%▼
2024 · 53.9%
Current ratio
0.08▼
2024 · 0.45
Debt to equity
-3.80▼
2024 · 0.86
ROA
-208.0%▼
2024 · 6.8%
Interest coverage
1.04▼
2024 · 9.20
Debt ≤ 1 year
€749,778▲
2024 · €223,618
Income taxes
€4,666▼
2024 · €35,502
Green means a favourable move, even when the figure itself falls: as with debt or debt to equity.
Annual accounts
| Line | 2021 | 2022 | 2023 | 2024 | 2024 | Change |
|---|---|---|---|---|---|---|
| Non-recurring operating income76A | - | €97,667 | - | - | €1,094 | - |
| Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets630 | €38,919 | €31,522 | €36,764 | €37,285 | €18,309 | - |
| Other operating charges640/8 | €3,701 | €4,508 | €3,235 | €3,349 | €1,617 | - |
| Non-recurring operating charges66A | - | - | - | - | €4,893 | - |
| Gross operating margin9900 | €223,154 | €228,136 | €200,268 | €217,723 | €15,142 | - |
| Operating profit (loss)9901 | €180,535 | €192,106 | €160,269 | €177,088 | -€9,676 | - |
| Financial income75/76B | €0 | - | €1,292 | €1,777 | €0 | - |
| Recurring financial income75 | €0 | - | €1,292 | €1,777 | €0 | - |
| Financial charges65/66B | €35,547 | €30,856 | €28,437 | €23,309 | €1.1m | - |
| Recurring financial charges65 | €35,547 | €30,856 | €28,437 | €23,309 | €8,284 | - |
| Non-recurring financial charges66B | - | - | - | - | €1.1m | - |
| Profit (loss) for the period before taxes9903 | €144,988 | €161,249 | €133,125 | €155,557 | -€1.1m | - |
| Income taxes67/77 | €43,394 | €50,838 | €39,437 | €35,502 | €4,666 | - |
| Profit (loss) for the period9904 | €101,594 | €110,412 | €93,688 | €120,054 | -€1.1m | - |
| Profit (loss) for the period to be appropriated9905 | €101,594 | €110,412 | €93,688 | €120,054 | -€1.1m | - |
| Line | 2021 | 2022 | 2023 | 2024 | 2024 | Change |
|---|---|---|---|---|---|---|
| Assets | ||||||
| Total assets20/58 | €1.9m | €1.8m | €1.8m | €1.8m | €552,421 | - |
| Fixed assets21/28 | €1.9m | €1.7m | €1.7m | €1.7m | €491,394 | - |
| Tangible fixed assets22/27 | €356,655 | €229,094 | €200,542 | €170,757 | €123,449 | - |
| Land and buildings22 | €356,655 | €185,221 | €159,743 | €141,758 | €123,449 | - |
| Furniture and vehicles24 | - | €43,873 | €40,799 | €28,999 | - | - |
| Financial fixed assets28 | €1.5m | €1.5m | €1.5m | €1.5m | €367,945 | - |
| Current assets29/58 | €78,754 | €75,218 | €120,187 | €100,765 | €61,027 | - |
| Amounts receivable within one year40/41 | €75,916 | €73,564 | €97,817 | €96,098 | €4,731 | - |
| Trade receivables40 | €66,000 | €36,000 | €56,411 | €52,500 | €4,731 | - |
| Other amounts receivable41 | €9,916 | €37,564 | €41,406 | €43,598 | - | - |
| Current investments50/53 | - | €10 | €10 | €10 | - | - |
| Cash at bank and in hand54/58 | - | €1,325 | €20,288 | €1,212 | €56,296 | - |
| Deferred charges and accrued income490/1 | €2,838 | €319 | €2,072 | €3,445 | - | - |
| Equity and liabilities | ||||||
| Total equity and liabilities10/49 | €1.9m | €1.8m | €1.8m | €1.8m | €552,421 | - |
| Equity10/15 | €667,695 | €778,107 | €871,795 | €951,849 | -€197,357 | - |
| Contributions10/11 | €18,600 | €18,600 | €18,600 | €18,600 | €18,600 | - |
| Reserves13 | €649,095 | €759,507 | €853,195 | €813,195 | €813,195 | - |
| Non-distributable reserves130/1 | €1,860 | €1,860 | €1,860 | - | - | - |
| Reserves not available under the articles1311 | €1,860 | €1,860 | €1,860 | - | - | - |
| Tax-exempt reserves132 | €5,936 | €5,936 | €5,936 | €5,936 | €5,936 | - |
| Distributable reserves133 | €641,299 | €751,711 | €845,399 | €807,259 | €807,259 | - |
| Profit (loss) carried forward14 | - | - | - | €120,054 | -€1.0m | - |
| Amounts payable17/49 | €1.3m | €1.0m | €943,510 | €814,249 | €749,778 | - |
| Amounts payable after more than one year17 | €1.0m | €847,654 | €725,442 | €590,630 | - | - |
| Financial debts170/4 | €1.0m | €847,654 | €725,442 | €590,630 | - | - |
| Amounts payable within one year42/48 | €220,495 | €169,627 | €218,069 | €223,618 | €749,778 | - |
| Current portion of amounts payable after more than one year42 | €155,817 | €146,697 | €149,226 | €131,170 | - | - |
| Financial debts43 | €397 | - | - | - | - | - |
| Credit institutions430/8 | €397 | - | - | - | - | - |
| Trade debts44 | €10,224 | €9,878 | €10,969 | €15,804 | €14,314 | - |
| Suppliers440/4 | €10,224 | €9,878 | €10,969 | €15,804 | €14,314 | - |
| Taxes, remuneration and social security45 | €26,937 | €13,052 | €4,814 | €7,357 | €324 | - |
| Taxes450/3 | €26,937 | €13,052 | €4,814 | €5,141 | €324 | - |
| Remuneration and social security454/9 | - | - | - | €2,217 | - | - |
| Other amounts payable47/48 | €27,120 | - | €53,060 | €69,287 | €735,140 | - |
| Accrued charges and deferred income492/3 | €3,500 | €3,500 | - | - | - | - |
| Line | 2021 | 2022 | 2023 | 2024 | 2024 | Change |
|---|---|---|---|---|---|---|
| Profit (loss) for the period9904 | €101,594 | €110,412 | €93,688 | €120,054 | -€1.1m | - |
| + Depreciation and write-downs630 | €38,919 | €31,522 | €36,764 | €37,285 | €18,309 | - |
| Operating cash flow (approximation) | €140,513 | €141,934 | €130,452 | €157,340 | -€1.1m | - |
| Investment in fixed assets (approximation) | - | €96,039 | -€8,213 | -€7,500 | - | - |
| Change in cash | - | - | €18,963 | -€19,076 | - | - |
Simplified and derived: a Belgian filing has no cash-flow statement, so these rows come from the income statement and the balance-sheet moves.
Timeline · acts, filings and financial milestones
2025
23-06
NBB filing
Annual accounts filed
fiscal year 2024 · full schema
2024
31-12
Financial
Weakest financial yearnet -€1.1m
Net result drops to -€1.1m, the lowest in the series.
01-10
NBB filing
Annual accounts filed
fiscal year 2024 · abbreviated schema
31-03
Financial
Highest result since 2019net €120,054 ▲28.1%
Net result €120,054, the highest in the series.
2023
27-10
NBB filing
Annual accounts filed
fiscal year 2023 · abbreviated schema
2022
05-12
NBB filing
Annual accounts filed
fiscal year 2022 · abbreviated schema · 35 days late
22-04
NBB filing
Annual accounts filed
fiscal year 2021 · abbreviated schema · 173 days late
2020
07-10
NBB filing
Annual accounts filed
fiscal year 2020 · abbreviated schema
31-03
Financial
Equity above €500,000Eq €566,101 ▲18.9%
2 profitable years in a row build equity to €566,101.
2019
28-10
NBB filing
Annual accounts filed
fiscal year 2019 · abbreviated schema
2018
10-10
NBB filing
Annual accounts filed
fiscal year 2018 · abbreviated schema
2017
04-10
NBB filing
Annual accounts filed
fiscal year 2017 · abbreviated schema
2016
16-09
NBB filing
Annual accounts filed
fiscal year 2016 · abbreviated schema
Financial milestoneNBB filingFinancial milestones sit on the fiscal year-end date, not the filing date.
0 of 11 acts read
About the unread acts
We know of 11 Belgian State Gazette acts for this company. None of them has been read yet: what they contain is neither established nor disproved here.
Have them read with priority
Sign in to place this company at the front of the reading queue.
Structure & network
Part of the group
MULTIPHARMA GROUP
10 companies
Group, risk and exposure
Owners and holdings
1 owner · 1 holdingChain of control
- MULTIPHARMA GROUP
- Multipharma
- FARMANNSO
Highest known parent: MULTIPHARMA GROUP. The sources do not say who stands above it.
Owners 1
- Multipharmaparent100%
Holdings 1
-
100%
According to the 2024 annual accounts of FARMANNSO and those of the other companies, the acts in the Belgian Gazette and the LEI register. The register of ultimate beneficial owners (UBO) is not public: who ultimately stands behind a natural person or a foreign parent is not stated here. A company that does not fill in these statements, or need not, is missing.
Connections & network
No current directors or connected companies found in the register.